New treatments for COVID-19 using nitazoxanide and ivermectin

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effectiveness of nitazoxanide and ivermectin in treating COVID-19. It aims to evaluate the clinical efficacy of these medications, both individually and in combination with other drugs like azithromycin and chloroquine. The study is designed as a Phase 3 interventional trial, focusing on patients diagnosed with COVID-19. By assessing various treatment regimens, the trial seeks to identify the most effective approach to combat this viral infection.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients with COVID-19 infection

Exclusion Criteria:

* Allergy or contraindication to the drugs.

Where it's running

• Tanta University, Assiut University
  Tanta, Egypt Recruiting
• Sherief Abd-Elsalam
  Tanta, Egypt Recruiting

Study contacts

• Principal investigator: sherief Abd-Elsalam, Ass. Prof. — ass. Prof. Tropical Medicine
• Study coordinator: Sherief Abd-Elsalam, ass. prof.
• Email: sheriefabdelsalam@yahoo.com
• Phone: 00201147773440

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Effects of suctioning on pain and stress in intubated ICU patients

  This study is testing if suctioning the breathing tube in ICU patients causes more pain and stress compared to not suctioning.

  Recruiting Loma Linda University · Loma Linda, California · NCT06692400

• Measuring flu vaccine immunity in COVID-19 patients

  This study looks at how well the flu vaccine works in people aged 13 to 64 who have had COVID-19, comparing their immune responses to those who haven't had the virus.

  Recruiting Stanford University · Palo Alto, California · NCT04579588

• Survey on COVID-19 impact in patients with primary immune deficiency

  This study is trying to learn how COVID-19 has affected people with primary immune deficiencies to better understand their experiences and outcomes.

  Recruiting Imagine Institute · Paris · NCT04459689

• Understanding how long COVID-19 can persist after recovery

  This study is trying to find out how long the COVID-19 virus can stick around in people who have recovered and how quickly their bodies make antibodies.

  Recruiting Columbia University · New York, New York · NCT04448145

• Understanding the long-term effects of COVID-19 infection

  This study looks at people who have recovered from COVID-19 to see how the infection affects their health over time.

  Recruiting University of California, San Francisco · San Francisco, California · NCT04362150

• Evaluating higher doses of Ivermectin for COVID-19 treatment

  This study is testing whether higher doses of Ivermectin can help people with COVID-19 feel better and recover faster.

  Recruiting Phase 2/3 Tanta University · Tanta · NCT04351347

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.